Progress on COVID Vaccines Has Sparked Celebration. But There’s A Long Way to Go Yet.
This article underscores the importance of cautious optimism regarding the positive results for early phase COVID-19 clinical vaccine trials. Drs. Ruth Karron and Kawsar Talaat say that data from upcoming Phase III trials is necessary to determine whether early data can be validated in larger numbers of vaccine recipients.